RE: Tech Crunch Article6 Aug 2021 03:23
Lenné argues that a camera-based approach would be far more successful than a breath or touch-based approach because BAC levels can rise within minutes. Someone could theoretically down a bunch of shots immediately before getting behind the wheel and it wouldn’t show up on a reading for several minutes. Or they could get wasted while driving. And BAC detection doesn’t help at all when it comes to drug-impaired driving.
“We’re trying to assess what’s going on in someone’s head, and that’s really different from having a forward-facing radar that’s trying to look at what’s 30 meters in front of you,” he said. “You’re trying to interpret whether or not this person is safe to drive. So it’s a really difficult technical problem to solve. Our company is 21 years old. Smart Eye has been around for over 10 years. Whilst the market size has increased dramatically, it’s a hard problem to solve as a new entrant.”
Newcomers will face competition from established and large Tier 1 suppliers like Seeing Machines and Smart Eye, a Swedish computer vision company that people familiar with the industry say works with Ford (Ford did not confirm or deny this). IndustryARC also names major players as Faurecia, Aptiv PLC, Bosch, Denso, Continental AG and others. But new players are finding their way into the scene, like Israel-based Cipia, formerly Eyesight Technology, and Sweden-based Tobii Tech.